Targeting Pain with Novel Therapeutics 2011
June 7 - 8, 2011
Philadelphia PA , USA
TARGETING ION CHANNELS
Sodium Channels as Therapeutic Targets in Pain: Many Isoforms, Many Actions, Many Opportunities
Stephen G. Waxman, M.D., Ph.D., Bridget Marie Flaherty Professor of Neurology, Neurobiology and Pharmacology, Yale University School of Medicine
Design and Pre-Clinical Development of Novel T-Type and N-Type Calcium Channel Blockers for Pain Intervention
Terrance P. Snutch, Ph.D., FCAHS, FRSC, Vice President & CSO, Zalicus, Inc.
THE ENDOCANNABINOID SYSTEM
Endocannabinoid-Based Therapies for Pain
Daniele Piomelli, Ph.D., Italian Institute of Technology, Genoa, Italy; University of California, Irvine
Talk Title to be Announced
Tim Young, Ph.D., Associate Research Fellow, Pfizer
Peripheral CB1/CB2 Agonist for the Treatment of Pain and Inflammation
Robert Spencer, Ph.D., Senior Director, Pre-Clinical Development, Cara Therapeutics
BIOLOGICS FOR PAIN
The Promise of Biologic Drugs for the Treatment of Pain
Iain Chessell, Ph.D., Head, Neuroscience Centre of Excellence, MedImmune
BIOMARKERS
Translational Models and Biomarkers for Pain Therapeutic Development
Mark R. Bowlby, Ph.D., Neurophysiology & Pain Lead, Merck Research Labs
microRNA as Biomarkers in Pain
Seena K. Ajit, Ph.D., Assistant Professor, Pharmacology and Physiology, Drexel University College of Medicine
Sodium Channels as Therapeutic Targets in Pain: Many Isoforms, Many Actions, Many Opportunities
Stephen G. Waxman, M.D., Ph.D., Bridget Marie Flaherty Professor of Neurology, Neurobiology and Pharmacology, Yale University School of Medicine
Design and Pre-Clinical Development of Novel T-Type and N-Type Calcium Channel Blockers for Pain Intervention
Terrance P. Snutch, Ph.D., FCAHS, FRSC, Vice President & CSO, Zalicus, Inc.
THE ENDOCANNABINOID SYSTEM
Endocannabinoid-Based Therapies for Pain
Daniele Piomelli, Ph.D., Italian Institute of Technology, Genoa, Italy; University of California, Irvine
Talk Title to be Announced
Tim Young, Ph.D., Associate Research Fellow, Pfizer
Peripheral CB1/CB2 Agonist for the Treatment of Pain and Inflammation
Robert Spencer, Ph.D., Senior Director, Pre-Clinical Development, Cara Therapeutics
BIOLOGICS FOR PAIN
The Promise of Biologic Drugs for the Treatment of Pain
Iain Chessell, Ph.D., Head, Neuroscience Centre of Excellence, MedImmune
BIOMARKERS
Translational Models and Biomarkers for Pain Therapeutic Development
Mark R. Bowlby, Ph.D., Neurophysiology & Pain Lead, Merck Research Labs
microRNA as Biomarkers in Pain
Seena K. Ajit, Ph.D., Assistant Professor, Pharmacology and Physiology, Drexel University College of Medicine
Related events
Targeting Pain with Novel Therapeutics June 4 - 6, 2015
Targeting Pain with Novel Therapeutics June 4 - 6, 2014
Targeting Pain with Novel Therapeutics June 4 - 6, 2013
Targeting Pain with Novel Therapeutics June 6 - 7, 2012
Targeting Pain with Novel Therapeutics June 7 - 8, 2011
